PodBites
🍐 In this episode of PodBites, Lamar Antari and Leen Al-Fadhel take listeners into the world of antipsychotic pharmacology, using clinical stories and neuroscience principles to explain how these medications help manage schizophrenia and other psychotic disorders. 🎙️ Tune in to explore: * The core symptom domains of schizophrenia — positive, negative, and cognitive symptoms * The dopamine hypothesis of schizophrenia and how imbalances in dopamine signaling contribute to psychosis * The four major dopamine pathways: mesolimbic, mesocortical, nigrostriatal, and tuberoinfundibular * How first-generation (typical) antipsychotics like haloperidol and chlorpromazine primarily work through D₂ receptor blockade * The major extrapyramidal side effects (EPS) including dystonia, akathisia, parkinsonism, and tardive dyskinesia * Important adverse effects such as hyperprolactinemia, orthostatic hypotension, sedation, and neuroleptic malignant syndrome * How second-generation (atypical) antipsychotics such as risperidone, quetiapine, aripiprazole, and clozapine target both dopamine and serotonin receptors * The trade-off between lower EPS risk but higher metabolic complications, including weight gain, insulin resistance, and dyslipidemia * Unique clinical features of key drugs like clozapine for treatment-resistant schizophrenia and the need for regular CBC monitoring due to agranulocytosis risk 🌟 A high-yield, clinically grounded guide to understanding how antipsychotics affect brain pathways, improve symptoms of psychosis, and why balancing efficacy with side-effect management is essential in psychiatric pharmacotherapy.
100 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de PodBites!